Lv1
96 积分 2021-04-09 加入
有志者,事竟成!
Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases
                                            26天前
                                            已完结
                                        
Distinct Role of TP53 Co-mutations in Different EGFR Subtypes Mediating the Response to EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
                                            1个月前
                                            已完结
                                        
Interferon-γ Drives Anti-Tumor Immunity in Leptomeningeal Metastasis: A Potential Therapeutic Strategy
                                            2个月前
                                            已完结
                                        
Leptomeningeal Metastasis from Non–Small Cell Lung Cancer and Current Landscape of Treatments
                                            2个月前
                                            已完结
                                        
Genomic profiling and prognostic factors of leptomeningeal metastasis in EGFR-mutant NSCLC after resistant to third-generation EGFR-tyrosine kinase inhibitors
                                            2个月前
                                            已完结
                                        
Transcriptomic heterogeneity of EGFR-mutant non-small cell lung cancer evolution towards small cell lung cancer
                                            2个月前
                                            已完结
                                        
NSCLC to SCLC Transformation: A Clinical Challenge
                                            2个月前
                                            已完结
                                        
Genomic profiling and prognostic factors of leptomeningeal metastasis in EGFR-mutant NSCLC after resistant to third-generation EGFR-tyrosine kinase inhibitors
                                            3个月前
                                            已完结
                                        
Immunotherapy-based therapy as a promising treatment for EGFR-mutant advanced non-small cell lung cancer patients after EGFR-TKI resistance
                                            3个月前
                                            已完结
                                        
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
                                            3个月前
                                            已完结